선천성 이상의 염색체마이크로어레이 검사 지침(I): 일반 및 산전검사 지침 = Practical Guidelines for Chromosomal Microarray Analysis for Constitutional Abnormalities: Part I, General and Prenatal

다국어 초록 (Multilingual Abstract)

Chromosomal microarray (CMA) testing can enhance the quality of clinical care for congenital abnormalities, including prenatal diagnosis. Laboratories require a comprehensive understanding of the strengths, weaknesses, and purposes of CMA testing. They should also have appropriate plans, guidelines, and documented records for platform validation and quality control at all stages of testing. Performing prenatal CMA testing necessitates understanding the features of prenatal specimens, devising a verification process, reporting results, and providing genetic counseling. This guideline aims to establish standard test protocols for conducting CMA tests, ensuring accurate results, and aiding in diagnosing and treating patients.

국문 초록 (Abstract)

염색체마이크로어레이 검사의 활용으로 산전진단을 포함한 선천성 이상에서 임상 진료의 질이 향상될 수 있다. 검사실은 염색체마이크로어레이 검사의 장단점과 목적을 잘 이해해야 하고, 검사의 도입, 변경, 수행 과정에서 플랫폼 검증 및 검사 모든 과정의 질관리에 대한 적절한 계획과 지침 및 문서화된 기록을 가지고 있어야 한다. 산전 CMA 검사는 산전검체의 특성을 이해하고, 거기에 부합하는 검증과정, 결과보고, 포괄적 유전상담에 대한 계획이 필요하다. 본 지침은 국내 CMA 검사 수행의 표준 검사 지침을 마련하고, 검사의 오류를 줄여 정확한 검사 및 해석을 제공함으로써 환자의 진단과 치료에 도움이 되고자 한다.

참고문헌 (Reference)

1 Dugoff L, "The use of chromosomal microarray for prenatal diagnosis" 215 : B2-B9, 2016

2 Riggs ER, "Technical standards for the interpretation and reporting of constitutional copy-number variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics(ACMG)and the Clinical Genome Resource(ClinGen)" 22 : 245-257, 2020

3 Hsu LY, "Proposed guidelines for diagnosis of chromosome mosaicism in amniocytes based on data derived from chromosome mosaicism and pseudomosaicism studies" 12 : 555-573, 1992

4 Armour CM, "Practice guideline : joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada" 55 : 215-221, 2018

5 Ministry of Health and Welfare, "Partial amendment of details on the application criteria and methods of medical care benefits. Notification no. 2019 – 166, Jul. 29, 2019"

6 Masri A, "Microarray delineation of familial chromosomal imbalance with deletion 5q35 and duplication 10q25 in a child showing multiple anomalies and dysmorphism" 164A : 1254-1261, 2014

7 Korean Institute of Genetic Testing Evaluation, "Korean Institute of Genetic Testing Evaluation inspection checklist for cytogenetic tests"

8 Korean Society of Medical Genetics and Genomics, "Guidelines for clinical practice of postnatal chromosomal microarray analysis. 2021"

9 The Korean Society for Laboratory Medicine, "Good laboratory inspection checklist: cytogenetic tests"

10 Clinical and Laboratory Standards Institute, "Genomic copy number microarrays for constitutional genetic and oncology applications" Clinical and Laboratory Standards Institute 2015

11 Cho SY, "Familial Xp22. 33-Xp22.12 deletion delineated by chromosomal microarray analysis causes proportionate short stature" 158A : 1462-1466, 2012

12 Silva M, "European guidelines for constitutional cytogenomic analysis" 27 : 1-16, 2019

13 Cherry AM, "Diagnostic cytogenetic testing following positive noninvasive prenatal screening results : a clinical laboratory practice resource of the American College of Medical Genetics and Genomics(ACMG)" 19 : 845-850, 2017

14 Zneimer SM, "Cytogenetic abnormalities: Chromosomal, FISH and microarray-based clinical reporting and interpretation of result" John Wiley & Sons, Inc 2014

15 Sismani C, "Cryptic genomic imbalances in patients with de novo or familial apparently balanced translocations and abnormal phenotype" 1 : 15-, 2008

16 Miller DT, "Consensus statement : chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies" 86 : 749-764, 2010

17 Group of consensus of the use of chromosomal microarray analysis in prenatal diagnosis, "Consensus of the use of chromosomal microarray analysis in prenatal diagnosis" 49 : 570-572, 2014

18 Committee on Genetics and the Society for Maternal-Fetal Medicine, "Committee Opinion No. 682 : Microarrays and Next-Generation Sequencing Technology : The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology" 128 : e262-e268, 2016

19 Brothman AR, "College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis" 13 : 765-769, 2011

20 Kohannim O, "Clinical findings associated with a de novo partial trisomy 10p11. 22p15. 3 and monosomy 7p22. 3 detected by chromosomal microarray analysis" 2011 : 131768-, 2011

21 Gardner RJM, "Chromosome abnormalities and genetic counseling" Oxford University Press 2011

22 Schreck RR, "Chromosomal mosaicism in chorionic villus sampling" 17 : 867-888, 1990

23 Wapner RJ, "Chromosomal microarray versus karyotyping for prenatal diagnosis" 367 : 2175-2184, 2012

24 Gill K, "Chromosomal microarray detects genetic risks of neurodevelopmental disorders in newborns with congenital heart disease" 31 : 1275-1282, 2021

25 Shao L, "Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision : a technical standard of the American College of Medical Genetics and Genomics(ACMG)" 23 : 1818-1829, 2021

26 Gu S, "Chromosomal microarray analysis on uncultured chorionic villus sampling can be complicated by confined placental mosaicism for aneuploidy and microdeletions" 38 : 858-865, 2018

27 Canadian College of Mmedical Geneticists Cytogenetics Committee, "CCMG Guidelines for Genomic Microarray Testing"

28 Manning M, "Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities" 12 : 742-745, 2010

29 Kearney HM, "American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants" 13 : 680-685, 2011

30 Kearney HM, "American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities" 13 : 676-679, 2011

31 Cooley LD, "American College of Medical Genetics and Genomics technical standards and guidelines : microarray analysis for chromosome abnormalities in neoplastic disorders" 15 : 484-494, 2013

32 South ST, "ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications : revision 2013" 15 : 901-909, 2013

33 Pinto IP, "A non-syndromic intellectual disability associated with a de novo microdeletion at 7q and 18p, microduplication at Xp, and 18q partial trisomy detected using chromosomal microarray analysis approach" 7 : 44-, 2014